Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
01 1Vamsi Labs
02 1TAPI Technology & API Services
03 1Johnson & Johnson Innovative Medicine
04 1MSN Laboratories
05 1Mankind Pharma
06 1Olon S.p.A
07 1R L Fine Chem
08 1RPG Life Sciences
09 1Sifavitor srl
10 1Teva Pharmaceutical Industries
11 1Blank
01 5India
02 2Israel
03 2Italy
04 1U.S.A
05 1Blank
01 5Active
02 1Inactive
03 5Blank
01 3Valid
02 8Blank
01 11Blank
01 1WC-0056
02 1WC-0383A8
03 9Blank
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-05-24
Pay. Date : 2015-07-23
DMF Number : 12530
Submission : 1997-05-28
Status : Active
Type : II
Available Reg Filing : CA, ASMF |
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-08-05
Pay. Date : 2012-12-13
DMF Number : 16949
Submission : 2003-11-10
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-11-14
Pay. Date : 2019-09-25
DMF Number : 33703
Submission : 2019-03-28
Status : Active
Type : II
Certificate Number : R0-CEP 2020-085 - Rev 01
Issue Date : 2022-05-30
Type : Chemical
Substance Number : 1431
Status : Valid
Date of Issue : 2021-02-12
Valid Till : 2022-08-08
Written Confirmation Number : WC-0383A8
Address of the Firm :
NDC Package Code : 69766-070
Start Marketing Date : 2019-03-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-03-30
Pay. Date : 2020-02-20
DMF Number : 34353
Submission : 2020-02-26
Status : Active
Type : II
Certificate Number : CEP 2020-080 - Rev 01
Issue Date : 2024-08-30
Type : Chemical
Substance Number : 1431
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10954
Submission : 1994-06-23
Status : Active
Type : II
Certificate Number : R1-CEP 2002-187 - Rev 04
Issue Date : 2014-06-12
Type : Chemical
Substance Number : 1431
Status : Valid
Date of Issue : 2022-06-03
Valid Till : 2025-07-28
Written Confirmation Number : WC-0056
Address of the Firm :
NDC Package Code : 17337-0519
Start Marketing Date : 2017-07-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6682
Submission : 1986-11-18
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Haloperidol Decanoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Haloperidol Decanoate, including repackagers and relabelers. The FDA regulates Haloperidol Decanoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Haloperidol Decanoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Haloperidol Decanoate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Haloperidol Decanoate supplier is an individual or a company that provides Haloperidol Decanoate active pharmaceutical ingredient (API) or Haloperidol Decanoate finished formulations upon request. The Haloperidol Decanoate suppliers may include Haloperidol Decanoate API manufacturers, exporters, distributors and traders.
click here to find a list of Haloperidol Decanoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 10 companies offering Haloperidol Decanoate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?